Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149

Reference

Title : Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study - Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
Author(s) : Blandizzi C , De Paolis B , Colucci R , Di Paolo A , Danesi R , Del Tacca M
Ref : Toxicol Appl Pharmacol , 177 :149 , 2001
Abstract : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
ESTHER : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
PubMedSearch : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
PubMedID: 11740913

Related information

Citations formats

Blandizzi C, De Paolis B, Colucci R, Di Paolo A, Danesi R, Del Tacca M (2001)
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study
Toxicol Appl Pharmacol 177 :149

Blandizzi C, De Paolis B, Colucci R, Di Paolo A, Danesi R, Del Tacca M (2001)
Toxicol Appl Pharmacol 177 :149